The situation was dire. As the pandemic raged in March, some Covid-19 patients in Milan were going into septic shock, and their blood pressure was perilously low.
A California drug company wanted to ship emergency medication to those patients, but commercial flights to Italy had been drastically scaled back. So it called PCI Pharma Services, a Philadelphia company that specialises in packaging and shipping drugs around the world. It took nearly a week, but PCI secured permits and arranged for courier jets, drivers and trains to deliver the drugs to Milan.
That day when the drug arrived, six people were saved, said Salim Haffar, PCIs chief executive.
As countries prepare to distribute hundreds of millions of Covid-19 vaccines some of which require storage as cold as the South Pole in winter and meticulous handling the highly specialised operations of companies like PCI Pharma are in heavy demand. And Wall Street, which likes nothing better than a hot trade with the potential for big profits, is rushing to grab a piece of the action.
Investors were already snapping up shares of vaccine-makers like Moderna and Pfizer, whose vaccine, developed with BioNTech, was introduced in the United States on Monday and requires an exceptionally low storage temperature of minus 70 Celsius (minus 94 degrees Fahrenheit). FedEx and UPS, whose shares have already risen this year as the pandemic forced millions to rely on online shopping, could benefit further from their roles in vaccine delivery.
Coronavirus vaccine news live updates on DH
But in recent months, private equity firms and wealthy individual investors have also been seizing on smaller companies like PCI Pharma, whose cold-storage operations will play a crucial role in delivering Covid vaccines to the public.
Until recently, the temperature-controlled storage and shipping of pharmaceutical products, known as the cold chain, was a relatively sleepy corner of the health care industry. The technology to preserve animal-based cells and tissues by transporting them in cold conditions has been available since the 1950s, and certain breakthroughs in cancer research in the last decade increased demand for cold-chain transportation.
But the virus, and the temperature-sensitive vaccines that are poised to combat it, have brought new attention to the cold-chain delivery systems in the United States and beyond. Even Saturday Night Live featured a cooler full of vaccines during a recent episode.
The companies getting attention from Wall Street are notable for how niche their operations are. Many use an elaborate network of freezers and specialised trucks and aircraft to move temperature-sensitive materials such as blood, stem cells and tissue around the world without compromising their efficacy. Its a delicate process, because a product can go from vital to useless within minutes of being removed from cold storage.
Potential investors are constantly calling Stirling Ultracold, whose freezer equipment is powering UPS freezer farms in Louisville, Kentucky, and the Netherlands, where vaccines will be stored. Theres not a day that goes by that an inquiry doesnt come in, said Dusty Tenney, Stirlings chief executive, who is running his Athens, Ohio, production lines around the clock.
Demand for Stirlings freezer engines the core component of its upright, under-the-counter and portable freezers has soared, and the estimated waiting time for new orders is six to eight weeks, the company said. On December 8, after multiple prospective investors studied the companys financial metrics in a due diligence process, Stirling received a capital injection of an undisclosed amount that it plans to use to buy new equipment and expand production.
In October, Blackstone, the private equity giant, invested $275 million in Cryoport, a Nashville, Tennessee company that specializes in shipping sensitive medical materials at freezing temperatures. Investors have also been bullish on Ember, the beverage-heating company that has developed a refrigerated medical shipping box with built-in GPS and already counts two Jonas Brothers and Brooklyn Nets forward Kevin Durant as shareholders.
For latest updates and live news on coronavirus, click here
PCI Pharma recently changed ownership. The new investors, private-equity firm Kohlberg & Co. and Abu Dhabi, United Arab Emirates, sovereign-wealth fund Mubadala Investment Co., viewed the companys expertise in transporting pharmaceuticals globally during the pandemic as a potential benefit.
Cold-chain investors said they were drawn to the area well before the pandemic because of the boom in biologic drugs, which require blood, tissue and other vital materials to be transported at low temperatures. For now, though, the rush to develop and distribute Covid-19 vaccines has amped up investors enthusiasm.
In addition to Pfizer and Moderna, AstraZeneca, Johnson & Johnson and others are also developing vaccines that will require cold storage. Therefore, cold-chain infrastructure, which can be limited in rural or far-flung areas like southeastern Indiana and Hawaii, will be essential.
Shares of Cryoport, which ships biologic material at cryogenic temperatures a level of freezing, usually around minus 150 Celsius, at which cells and other living materials enter a quiescent state are up more than 180% this year. Already, the company has transported temperature-sensitive materials involved in 26 different Covid vaccines and treatments and has a long-term partnership with McKesson, a distributor of medical supplies that has been tapped by the US government to manage domestic vaccine distribution.
Jerrell Shelton, Cryoports chief executive, said he expected the company to be involved in the global distribution of the vaccine, but the details had not yet been determined. This is a massive, massive effort, and its going to strain the temperature-control supply chain throughout the world, he said.
Ram M. Jagannath, a senior managing director at Blackstone who oversees the firms investment in Cryoport, said that the cell and gene-based therapies market in which the company operates is likely to grow at an annualised rate of 50% for the next five years. The current pandemic has only served to increase interest and investment in these potentially lifesaving therapies, Jagannath said. We invested in this for the long run.
CORONAVIRUS SPECIAL COVERAGE ONLY ON DH
Then there are companies like Ember, which is hoping to parlay its temperature-control technology currently used in a smart mug that keeps beverages at the users preferred drinking temperature into a shipping container for the Covid vaccine. Several years ago, Ember built a portable refrigerator for Mayo Clinic physicians trying to deliver vaccines to places where dry ice and cooling facilities were scarce.
We tested it, and we got huge positive feedback, said Clay Alexander, Embers chief executive.
That led to the creation of Embers cold box, which can ship medical products at standard refrigeration temperatures and generate its own electronic return labels on arrival a product it plans to take wider next year through a commercial partnership it signed recently. Investors in Ember are hoping that the technology will also come in handy as delivery of Covid vaccines becomes more widespread.
Much of the cold-chain infrastructure for pharmaceuticals was already in place in 2014, when veteran health care investor Matthew J. Jennings attended a gathering of the cold-chain industrys trade association in Chicago.
I was surprised at the size of the industry and the number of exhibitors searching for growth, said Jennings, an operating partner at Kohlberg who is now chairman of PCI Pharma. Growth, he said, has accelerated since then, and will likely benefit again as a result of Covid.
On November 20, a shipment of a Covid vaccine PCI Pharmas Haffar wouldnt say which one arrived at the companys headquarters as part of a dry run, escorted by armed US marshals.
The vials containing the vaccine were stored in a PCI refrigerator set between 2 and 8 degrees Celsius and monitored constantly. Once ready for packaging, the vials were removed from storage and brought to a machine where they were labelled and boxed before being returned to cold storage.
Haffar gave a tour recently of the companys Philadelphia building. Inside a walk-in cooler and wearing a long-sleeved gown and hairnet, he motioned to the surrounding shelves. They contained rows and rows of products that PCI packages, including drugs that treat Crohns disease and syringes that inject medicines directly into the eye.
The cold chain has been around forever, he said. The vaccine just made the sheer size of it bigger.
Read the original:
The unsexy side of Covid-19 vaccines gets Wall Streets attention - Deccan Herald
- Diversifying marrow registry critical to achieve medical equity say advocates - WISH TV Indianapolis, IN - September 16th, 2022
- COVID-19 vaccine is a gift that is saving lives - CatholicPhilly.com - December 24th, 2021
- Biology for Kids: The Movement of Substances in and out of ... - December 10th, 2021
- Stem cell laws and policy in the United States - Wikipedia - December 10th, 2021
- IU School of Medicine researchers discover new potential for functional recovery after spinal cord injury - Spinal News International - July 21st, 2021
- Stem Cell Treatment Centers - Indiana Stem Cell | Call Today - June 23rd, 2021
- Stem Cell Therapy | Indiana Medical Center - June 23rd, 2021
- Blocking energy pathway reduces GVHD while retaining anti-cancer effects of T-cells - Science Codex - November 10th, 2020
- Notre Dame Adjusts to the COVID-19 Pandemic | Notre Dame Magazine | University of Notre Dame - ND Newswire - July 7th, 2020
- Head of FDA urged to ensure any COVID vaccine be free of abortion connection - My catholic standard - April 23rd, 2020
- What Explains The COVID-19 Race Gap? : Shots - Health News - NPR - April 23rd, 2020
- If Social Distancing Is Impossible in Prisons, People Should Be Freed - Truthout - March 20th, 2020
- Blood drive to honor Franklin child with cancer - Daily Journal - January 27th, 2020
- Spinal Stenosis and Stem Cell Therapy ... - Indiana Polyclinic - January 9th, 2020
- Innovative Cellular Therapeutics Appoints Cell and Gene Therapy Manufacturing Expert Christopher Ballas, Ph.D., as SVP of Manufacturing - BioSpace - January 9th, 2020
- Robots help them 'find their passion' - News Dispatch - January 9th, 2020
- Seeking the Killer Space App with Space Tango - The Planetary Society - December 3rd, 2019
- 15 Antiviral Herbs to Keep You Healthy - Healthline - October 21st, 2019
- Juul Temporarily Halts Online Sales Of Flavored E-Cigarettes, But Critics Say That's Far From Enough - Kaiser Health News - October 21st, 2019
- When You Need Stem Cells, You May Appreciate the Donor Registry - 93.1 WIBC Indianapolis - September 22nd, 2019
- Research suggests new approach for treating inflammation - ScienceBlog.com - September 22nd, 2019
- Reviewing Assembly Biosciences Inc. (ASMB)'s and Neuralstem Inc. (NASDAQ:CUR)'s results - CryptoCoinsTribune - September 22nd, 2019
- A New Vaccine Could Mean the End of Polio - The National Interest Online - September 22nd, 2019
- Bone Marrow & Blood Stem Cell Transplant | IU Health - May 5th, 2019
- Stem Cell Research Facilities - Indiana Stem Cell - May 1st, 2019
- Stem Cell Therapy and Irritable Bowel Syndrome - Indiana ... - April 5th, 2019
- Learn more about Stem Cell Therapy in Fort Wayne Indiana ... - October 6th, 2018
- Stem Cell Treatment Program - Indiana Polyclinic - July 3rd, 2018
- Stem Cell Treatment Center | IN - July 3rd, 2018
- Regenerative Cell Therapy in Fort Wayne, Indiana - June 22nd, 2018
- IUPUI researchers finding collaboration, breakthroughs in lab facility - IU Newsroom - September 6th, 2017
- South Bend man a 'walking miracle' after cancer treatment ... - South Bend Tribune - September 4th, 2017
- Somatic SNAFUCan a Few Mutant Microglia Cause Neurodegenerative Disease? - Alzforum - September 4th, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - Northeast Indiana Public Radio - September 4th, 2017
- News | Misericordia University: Alumnus tells first-year students they ... - Misericordia University - August 25th, 2017
- Washington University School of Medicine; Asterias Biotherapeutics ... - STL.News - August 25th, 2017
- Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical Trial - GlobeNewswire (press release) - August 9th, 2017
- Dance event aims to raise funds for cancer research - Daily Journal - August 7th, 2017
- Asterias Biotherapeutics Opens Two Additional Clinical Sites for ... - GlobeNewswire (press release) - August 7th, 2017
- Want more stem cells and a higher pain tolerance? Try ... - July 30th, 2017
- Chris Rickert: Science skeptics shouldn't steer UW hiring - Madison.com - July 4th, 2017
- The Benefits of Stem Cell Science to Your Health - November 25th, 2016
- Guidelines for Preventing Opportunistic Infections Among ... - September 5th, 2016
- Hematopoietic stem/progenitor cells, generation of induced ... - July 29th, 2016
- Indiana (Stem Cell) - what-when-how - July 25th, 2016
- Stem Cells and Development - Mary Ann Liebert, Inc. - October 19th, 2015
- StemEnhance Increase Adult Stem Cells from Bone Mirrow - October 19th, 2015
- Ethics of Stem Cell Research (Stanford Encyclopedia of ... - October 6th, 2015
- Faculty Positions in Stem Cell Biology, Employment | ASCB - September 30th, 2015
- Stem Cell Discoveries - About.com Education - September 19th, 2015
- Munster veterinary clinic offers stem cell therapy - July 2nd, 2015
- IUPUI biologist receives NIH grant to study how glaucoma develops in stem cells - March 10th, 2015
- Significant Findings in U.S. National Institutes of Health's Trial of Pluristem's PLX-R18 Cells for Treatment of Acute ... - February 19th, 2015
- IU researchers create the inner ear from stem cells ... - February 10th, 2015
- What's the role of virtues in the lab? - February 3rd, 2015
- Stem Cell News | Stem Cell Treatment, Stem Cell Research ... - December 24th, 2014
- Dr. Nia Smyrniotis at The Miami Stem Cell Treatment Center - December 24th, 2014
- Key mechanism, potential target to prevent leukemia found - November 14th, 2014
- IUPUI Stem Cell Research Could Expand Clinical Use of ... - October 15th, 2014
- Researchers Develop New Cells Meant to Form Blood Vessels, Treat Peripheral Artery Disease - October 14th, 2014
- Bone Marrow and Stem Cell Transplant Treatment | Simon ... - September 1st, 2014
- Spinal Stem Cell Treatment IN | Spinal Pain Treatment IN ... - August 26th, 2014
- Indiana University (Stem Cell) - what-when-how - August 24th, 2014
- Indiana Stem Cell Treatment Center - August 22nd, 2014
- Spinal Disc Treatment IN | Disc Pain Treatment IN | Dr ... - August 22nd, 2014